Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . October 21st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis - Intermittent SNMC as effective as daily therapy for lowering liver enzyme levels
Hepatitis C Complications - Autoimmune disorder more common in chronic hepatitis C than suspected
Hepatitis B Vaccine - Novel 12-month regimen protects youth after hepatitis B vaccination
Hepatitis C - New combination treatment reported more beneficial than standard therapy
Hepatitis C Therapy - Few veterans achieve sustained viral response in treatment trial
Blood Safety - TIGRIS instrument system to be used for clinical diagnostic testing
Drug Development - AIDS researchers split GSK award
Hepatitis B - Phase II clinical trial of ISS vaccine initiated
Hepatitis C - Positive results reported on interferon-alpha variants
Hepatitis Immunization - Rates remain less than half for gay and bisexual men
Hepatocellular Carcinoma - Doctors predict success in percutaneous ethanol injection for liver cancer
Vector Development - BioVex announces gene therapy, cancer vaccine agreements
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
